Sun H. Kim-Hwa Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Factors governing tumor penetration of nanomedicines: intrinsic and extrinsic determinants.

Factors governing tumor penetration of nanomedicines: intrinsic and extrinsic determinants.

Journal: Nanoscale
Published: January 12, 2026

Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injury.

Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injury.

Journal: Journal of nanobiotechnology
Published: December 05, 2025

Preface: A new era of RNA-based therapies.

Preface: A new era of RNA-based therapies.

Journal: Advanced drug delivery reviews
Published: December 22, 2023

Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery.

Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery.

Journal: Biomaterials research
Published: June 12, 2023

Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis.

Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis.

Journal: Biomaterials
Published: December 29, 2021

PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1high tumors and TAMs.

PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1high tumors and TAMs.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 30, 2021

Versatile activatable vSIRPα-probe for cancer-targeted imaging and macrophage-mediated phagocytosis of cancer cells.

Versatile activatable vSIRPα-probe for cancer-targeted imaging and macrophage-mediated phagocytosis of cancer cells.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 04, 2019

Synergistic antitumor effects of combination treatment with metronomic doxorubicin and VEGF-targeting RNAi nanoparticles.

Synergistic antitumor effects of combination treatment with metronomic doxorubicin and VEGF-targeting RNAi nanoparticles.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 07, 2017

Synergistic anti-tumor effects of bevacizumab and tumor targeted polymerized VEGF siRNA nanoparticles.

Synergistic anti-tumor effects of bevacizumab and tumor targeted polymerized VEGF siRNA nanoparticles.

Journal: Biochemical and biophysical research communications
Published: May 16, 2017

Rolling circle transcription-based polymeric siRNA nanoparticles for tumor-targeted delivery.

Rolling circle transcription-based polymeric siRNA nanoparticles for tumor-targeted delivery.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 02, 2016

Simultaneous regulation of apoptotic gene silencing and angiogenic gene expression for myocardial infarction therapy: Single-carrier delivery of SHP-1 siRNA and VEGF-expressing pDNA.

Simultaneous regulation of apoptotic gene silencing and angiogenic gene expression for myocardial infarction therapy: Single-carrier delivery of SHP-1 siRNA and VEGF-expressing pDNA.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 02, 2016

RAGE siRNA-mediated gene silencing provides cardioprotection against ventricular arrhythmias in acute ischemia and reperfusion.

RAGE siRNA-mediated gene silencing provides cardioprotection against ventricular arrhythmias in acute ischemia and reperfusion.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 19, 2015
Showing 1-12 of 17

Last Updated: 09/26/2026